Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-12 4:11 pm Purchase | 13G | Forte Biosciences Inc. FBRX | BIOTECHNOLOGY VALUE FUND L P | 1,344,262 9.99% | 254,279 (+23.33%) | View |
| 2021-02-12 4:09 pm Sale | 13G | Corvus Pharmaceuticals Inc. CRVS | BIOTECHNOLOGY VALUE FUND L P | 2,898,797 9.99% | -22,380 (-0.77%) | View |
| 2021-02-12 4:06 pm Purchase | 13G | Cidara Therapeutics Inc. CDTX | BIOTECHNOLOGY VALUE FUND L P | 4,461,494 9.99% | 1,092,736 (+32.44%) | View |
| 2021-02-11 5:29 pm Sale | 13G | MEI Pharma Inc. MEIP | BIOTECHNOLOGY VALUE FUND L P | 5,589,315 4.9% | -1,297,110 (-18.84%) | View |
| 2021-02-11 5:27 pm Purchase | 13G | CytomX Therapeutics Inc. CTMX | BIOTECHNOLOGY VALUE FUND L P | 5,576,471 12.1% | 950,060 (+20.54%) | View |
| 2021-02-11 5:25 pm Sale | 13G | CALITHERA BIOSCIENCES INC CALA | BIOTECHNOLOGY VALUE FUND L P | 4,361,238 6.2% | -2,729,400 (-38.49%) | View |
| 2021-02-11 5:23 pm Sale | 13G | MOLECULAR TEMPLATES INC NE MTEM | BIOTECHNOLOGY VALUE FUND L P | 2,761,121 5.5% | -847,211 (-23.48%) | View |
| 2021-02-11 5:20 pm Purchase | 13G | ESSA Pharma Inc. EPIX | BIOTECHNOLOGY VALUE FUND L P | 3,705,289 11% | 1,064,724 (+40.32%) | View |
| 2021-02-11 5:18 pm Sale | 13G | Forward Pharma A/S FWPAY | BIOTECHNOLOGY VALUE FUND L P | 10,194,786 10.7% | -3,897,950 (-27.66%) | View |
| 2021-02-11 5:16 pm Sale | 13G | SpringWorks Therapeutics Inc. SWTX | BIOTECHNOLOGY VALUE FUND L P | 50 1% | -3,079,105 (-100.00%) | View |
| 2021-02-11 5:14 pm Purchase | 13G | GLYCOMIMETICS INC GLYC | BIOTECHNOLOGY VALUE FUND L P | 9,544,262 19.96% | 2,182,461 (+29.65%) | View |
| 2021-02-11 5:12 pm Sale | 13G | Replimune Group Inc. REPL | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -2,309,109 (Position Closed) | View |
| 2021-02-11 5:10 pm Sale | 13G | Surface Oncology Inc. SURF | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -2,125,650 (Position Closed) | View |
| 2021-02-11 5:08 pm Sale | 13G | MERSANA THERAPEUTICS INC MRSN | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -3,755,553 (Position Closed) | View |
| 2021-02-11 5:06 pm Purchase | 13G | IDEAYA Biosciences Inc. IDYA | BIOTECHNOLOGY VALUE FUND L P | 3,226,769 11.1% | 2,597 (+0.08%) | View |
| 2021-02-11 4:59 pm Sale | 13G | Kura Oncology Inc. KURA | BIOTECHNOLOGY VALUE FUND L P | 1,245,912 1.9% | -1,188,784 (-48.83%) | View |
| 2021-02-11 4:52 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | BIOTECHNOLOGY VALUE FUND L P | 3,114,250 4.7% | 3,114,250 (New Position) | View |
| 2021-02-11 4:43 pm Sale | 13G | CURIS INC PAR $0.01 CRIS | BIOTECHNOLOGY VALUE FUND L P | 626,945 1% | -3,023,055 (-82.82%) | View |
| 2021-02-11 4:41 pm Sale | 13G | ANAPTYSBIO INC ANAB | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -1,441,565 (Position Closed) | View |
| 2021-02-11 4:33 pm Sale | 13G | CELLDEX THERAPEUTICS INC C CLDX | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -2,740,000 (Position Closed) | View |